Strategies to Stay Ahead of the Curve
AIRED 20 MAY 2020
PEG CROWLEY-NOWICK, PHD, MBA | CHRISTOPHER KEIR, MD, MS
Keep Your Business Moving Even When You Can’t Be Together
As part of the increasing concerns around today’s global health and safety issues, maintaining business continuity is vital to our Clients and ultimately their patients. Zipher can help ensure your continued operation with engaging and interactive workshops, team meetings and advisory boards, all executed using our virtual capabilities.
Integrate Medical Planning and Execution
Zipher’s time-efficient process helps your team think strategically, grasp their roles, and successfully gain alignment across medical, commercial, and research & development. All strategies and tactics are customized to each client’s needs and implemented according to their internal resources and timelines.
Accelerate Launch Readiness
Accelerate access and integrate a new drug into clinical practice. Communicate the data, how it fits into the landscape, how it brings value to patients and payers, how it informs and educates the medical community, so that the right drug gets to the right patient at the right time.
Translate Data into Action
Use quantitative and qualitative real-word insights to understand the global impact of your clinical data, assess gaps and define the continuing data needs of healthcare decision makers. Build a data generation strategy designed to stay ahead of the evolving landscape throughout the product lifecycle.
Cultivate Leadership and Talent
The true value of medical affairs is not as a support function but an equal partner with commercial and research & development. Success today requires your medical team to demonstrate leadership and understand the pharmaceutical business. Zipher assesses your organizational structure, recognizes gaps, defines resources needed, and identifies and trains scientists and clinicians to build medical leadership.
Defining the Course &
Navigating the Finish Line
Read why life science companies need Medical Affairs in today’s highly competitive pharmaceutical landscape.